Table 1.
Sample characteristics for HCV and HCV with HCC groups
| Variable | Group (All subjects were HCV positive) | |||
|---|---|---|---|---|
| Overall (N=32,806) | No HCC (n=32,544) | HCC (n=262) | Statistic | |
| n (%) | n (%) | n (%) | p value (χ2/t-test) | |
| Sex | ||||
| Male | 19,212 (58.6) | 19,038(58.5) | 174(66.4) | 0.01 |
| Female | 13,594 (41.4) | 13,506(41.5) | 88(33.6) | |
| Race | ||||
| Caucasian | 15,368 (46.8) | 15,255(46.9) | 113(43.1) | |
| Asian | 939 (2.9) | 919(2.8) | 20(7.6) | |
| African American | 15,449 (47.1) | 15,330(47.1) | 119(45.4) | <0.001 |
| Native American | 516 (1.6) | 511(1.6) | 5(1.9) | |
| Other | 534 (1.6) | 529(1.6) | 5(1.9) | |
| Age (M±SD) (yrs) | 56.6 ± 15.3 | 56.6 ± 15.3 | 59.6 ± 12.4 | 0.001 |
| Range (4.0–95.4) | (4.0–95.4) | (17.4–84.7) | ||
| Duration on | 6.1 ± 3.8 | 6.1 ± 3.8 | 5.6 ± 3.5 | 0.04 |
| dialysis (M±SD) (yrs) | Range (1.3–33.3) | (1.3–31.6) | (1.3–33.3) | |
| Co-morbidity | ||||
| Hepatitis B | 12,142 (37.0) | 12,077 (37.1) | 65 (24.8) | <0.001 |
| Diabetes | 10,816 (33.0) | 10,714 (32.9) | 102 (38.9) | 0.04 |
| Cirrhosis | 3,765 (11.5) | 3,609 (11.1) | 156 (59.5) | <0.001 |
| Alcohol Abuse | 3,105 (9.5) | 3,039 (9.3) | 66 (25.2) | <0.001 |
| Drug Abuse | 2,919 (8.9) | 2,910 (8.9) | 9 (3.4) | 0.003 |
| HIV | 2,846 (8.7) | 2,843 (8.7) | 12 (4.6) | 0.02 |